首页    期刊浏览 2024年07月19日 星期五
登录注册

文章基本信息

  • 标题:Phorbol Myristate Acetate Stimulates Degradation of a Structural Analogue of Platelet-Activating Factor to a Neutral Lipid in Human Leukemic K562 Cells: Relevance to the Release of Lipids
  • 本地全文:下载
  • 作者:Toshihiko Tsutsumi ; Akira Tokumura ; Masaya Yamaguchi
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2004
  • 卷号:27
  • 期号:1
  • 页码:24-28
  • DOI:10.1248/bpb.27.24
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:In our attempt to investigate the mechanism of the release of platelet-activating factor (PAF) from cells, the erythroleukemic cell line K562 was preloaded with a radiolabeled PAF analogue having an ethylcarbamyl residue, 1- O -octadecyl-2- O -ethylcarbamyl- s n-glycero-3-phosphocholine (ethylcarbamyl-PAF), that is resistant to the hydrolytic action of PAF acetylhydrolase. Its extracellular release was monitored using an albumin back-extraction method, and its metabolic degradation was analyzed by TLC. Phorbol myristate acetate (PMA) was found to stimulate the release of two radioactive lipids, ethylcarbamyl-PAF itself and its metabolite, 1- O -octadecyl-2-ethylcarbamyl- sn -glycerol, whereas only ethylcarbamyl-PAF was released from the resting cells. The increased release of radioactive lipids in PMA-stimulated cells was suggested to be due to stimulated degradation of intracellular ethylcarbamyl-PAF into the cell-permeable metabolite. Thus K562 cells have much less capacity to release intact PAF-like lipid in comparison with its high ability to uptake exogenously added PAF analogues previously described by us and others.
  • 关键词:platelet-activating factor (PAF);PAF analogue;phorbol myristate acetate;K562 cell;octadecyl-ethylcarbamyl-glycerol
国家哲学社会科学文献中心版权所有